Zhu et al. demonstrated that tumor infiltration by M2-polarized TAMs and MDSCs could be reduced in a mouse model of pancreatic ductal adenocarcinoma with colony-stimulating factor 1 receptor (CSF1R) inhibitors. The gene discussed is CSF1R; the disease is pancreatic ductal adenocarcinoma.